(Q40331436)

19 September 2017

title

Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes (English)

1 reference

19 September 2017

0 references

1 reference

Alexandra Kautzky-Willer

10

object named as

Kautzky-Willer A

1 reference

19 September 2017

Farhan S

1

1 reference

19 September 2017

Winzer C

2

1 reference

19 September 2017

Tura A

3

1 reference

19 September 2017

Quehenberger P

4

1 reference

19 September 2017

Bieglmaier C

5

1 reference

19 September 2017

Wagner OF

6

1 reference

19 September 2017

Huber K

7

1 reference

19 September 2017

Waldhäusl W

8

1 reference

19 September 2017

Pacini G

9

1 reference

19 September 2017

publication date

1 May 2006

1 reference

European Journal of Clinical Investigation

19 September 2017

published in

1 reference

19 September 2017

volume

36

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

345-352

1 reference

Gestational diabetes mellitus: controversies and current opinions

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Plasminogen-activator inhibitor type 1 and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh artery study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

High proinsulin levels precede first-ever stroke in a nondiabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01630.X

10.1111/J.1365-2362.2006.01630.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference